HERON THERAPEUTICS, INC. /DE/ (HRTX)
Score window: May. 30, 2025 to May. 29, 2026
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Sep. 12, 2025 | CORRESP | Neutral/Informational | Moderate | Heron Therapeutics, Inc. has submitted a request to the SEC for the acceleration of the effective date of their Registration Statement on Form S-3. They are seeking to have the st… | Read Filing EDGAR |
| Sep. 12, 2025 | CORRESP | Neutral/Informational | Moderate | Heron Therapeutics, Inc. has submitted a request to the SEC for the acceleration of the effective date of their Registration Statement on Form S-3, originally filed on September 9… | Read Filing EDGAR |
| Sep. 11, 2025 | UPLOAD | Neutral/Informational | Low | The SEC correspondence dated September 11, 2025, informs Craig Collard, CEO of Heron Therapeutics, Inc., that the SEC has not reviewed and will not review the company's registrati… | Read Filing EDGAR |
| Sep. 11, 2025 | UPLOAD | Neutral/Informational | Low | The SEC correspondence dated September 11, 2025, informs Heron Therapeutics, Inc. that their registration statement on Form S-3, filed on September 9, 2025, will not be reviewed b… | Read Filing EDGAR |